

The innovation presented here provides a substance and application thereof which is
suitable to be utilized as drug both in human and in veterinary medicine to counteract bronchoconstriction (narrowing of the airways) and its spasmodic form, bronchial spasm, due to the muscle-relaxing properties of the substance.
Further Information: PDF
TransMIT Gesellschaft für Technologietransfer mbH
Phone: +49 (0)641/943 64-12
Contact
Dr. Peter Stumpf